Sana Biotechnology (SANA) Current Assets (2020 - 2026)

Sana Biotechnology's Current Assets history runs 7 years deep, the most recent figure standing at $111.7 million for Q1 2026.

• In Q1 2026, Current Assets fell 0.92% year-over-year to $111.7 million; the TTM figure through Mar 2026 stood at $111.7 million (down 0.92% YoY), while the FY2025 annual figure was $148.7 million, down 7.54% from the prior year.
• Current Assets came in at $111.7 million for Q1 2026 at Sana Biotechnology, down from $148.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $523.2 million in Q1 2022 to a low of $82.5 million in Q2 2025.
• A 5-year average of $278.6 million and a median of $263.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets sank 68.68% in 2025 and dropped 0.92% in 2026, its largest moves.
• Sana Biotechnology's Current Assets stood at $444.4 million in 2022, then slumped by 51.96% to $213.5 million in 2023, then decreased by 24.69% to $160.8 million in 2024, then slipped by 7.54% to $148.7 million in 2025, then dropped by 24.88% to $111.7 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $111.7 million, $148.7 million, and $161.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison